India — Nuts and Edible Seeds

← back to leaderboard

India received 181 FDA import refusals in Nuts and Edible Seeds between 2023-Q4 and 2026-Q3. Volume peaked at 30 in 2024-Q3, with the trend falling year-on-year. The most-cited issues are mfr insan, mfr inj, and poisonord. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 177 were hazard refusals and 4 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

22 2023-Q4 2023-Q4: 22 18 2024-Q1 2024-Q1: 18 12 2024-Q2 2024-Q2: 12 30 2024-Q3 2024-Q3: 30 14 2024-Q4 2024-Q4: 14 11 2025-Q1 2025-Q1: 11 7 2025-Q2 2025-Q2: 7 28 2025-Q3 2025-Q3: 28 9 2025-Q4 2025-Q4: 9 11 2026-Q1 2026-Q1: 11 7 2026-Q2 2026-Q2: 7 12 2026-Q3 2026-Q3: 12

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Other-Nuts 129 1,011 poisonord
Groundnut 19 672.8 mfr insan
Sesame 34 195.6 pesticide
Cashew 1 salmonella

Recent rejections